Stratatech Acquisition Becomes Final, CEO Says Jobs Will Stay in Madison
Stratatech Corp., whose human skin tissue products are used to heal severe burns, is now part of Mallinckrodt Pharmaceuticals, based in the United Kingdom.
The acquisition was completed Wednesday; terms were not disclosed. But Stratatech will remain in Madison and will keep all of its 55 jobs, CEO and founder Lynn Allen-Hoffmann told the Wisconsin State Journal.
The acquisition was completed Wednesday; terms were not disclosed. But Stratatech will remain in Madison and will keep all of its 55 jobs, CEO and founder Lynn Allen-Hoffmann told the Wisconsin State Journal.